Radiobiologic Optimization of Combination Radiopharmaceutical Therapy Applied to Myeloablative Treatment of Non-Hodgkin Lymphoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Radiobiologic Optimization of Combination Radiopharmaceutical Therapy Applied to Myeloablative Treatment of Non-Hodgkin Lymphoma

Published:2013-08-05 Issue:9 Volume:54 Page:1535-1542
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Hobbs Robert F.,Wahl Richard L.,Frey Eric C.,Kasamon Yvette,Song Hong,Huang Peng,Jones Richard J.,Sgouros George

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference35 articles.

1. Radioimmunoconjugates in acute leukemia treatment: the future is radiant

2. Relationships between tumor size and curability for uniformly targeted therapy with beta-emitting radionuclides;O'Donoghue;J Nucl Med.,1995

3. Tumour control probability derived from dose distribution in homogeneous and heterogeneous models: assuming similar pharmacokinetics,125Sn–177Lu is superior to90Y–177Lu in peptide receptor radiotherapy

4. Cohort Study of Somatostatin-Based Radiopeptide Therapy With [90Y-DOTA]-TOC Versus [90Y-DOTA]-TOC Plus [177Lu-DOTA]-TOC in Neuroendocrine Cancers

5. Clinical results of radionuclide therapy of neuroendocrine tumours with 90Y-DOTATATE and tandem 90Y/177Lu-DOTATATE: which is a better therapy option?

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted Treatment of Various Cancers using Radionuclide: Advancement and Prospective;Current Cancer Therapy Reviews;2024-05-31

2. Membrane and Nuclear Absorbed Doses from¹⁷⁷Lu and¹⁶¹Tb in Tumor Clusters: Effect of Cellular Heterogeneity and Potential Benefit of Dual Targeting—A Monte Carlo Study;Journal of Nuclear Medicine;2023-06-15

3. Dosimetry in Radiopharmaceutical Therapy;Journal of Nuclear Medicine;2022-10

4. I-124 PET/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response;Annals of Nuclear Medicine;2022-02-04

5. Dosimetry for Radiopharmaceutical Therapy: Current Practices and Commercial Resources;Journal of Nuclear Medicine;2021-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3